Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
133,846,019
-
Total 13F shares
-
7,585,892
-
Share change
-
+5,013,208
-
Total reported value
-
$4,970,520
-
Price per share
-
$0.66
-
Number of holders
-
23
-
Value change
-
+$3,317,939
-
Number of buys
-
11
-
Number of sells
-
7
Institutional Holders of NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN) as of Q4 2024
As of 31 Dec 2024,
NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,585,892 shares.
The largest 10 holders included
Pathstone Holdings, LLC, METEORA CAPITAL, LLC, UNIVERSITY OF CHICAGO, Diametric Capital, LP, Kepos Capital LP, VANGUARD GROUP INC, Sequoia Financial Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, ADVISORY RESEARCH INC, and XTX Topco Ltd.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.